<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">N Engl J Med</journal-id>
        <journal-id journal-id-type="iso-abbrev">N. Engl. J. Med.</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>The New England journal of medicine</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0028-4793</issn>
        <issn pub-type="epub">1533-4406</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC3767041</article-id>
        <article-id pub-id-type="pmcid-ver">PMC3767041.1</article-id>
        <article-id pub-id-type="pmcaid">3767041</article-id>
        <article-id pub-id-type="pmcaiid">3767041</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS491910</article-id>
        <article-id pub-id-type="pmid">23634996</article-id>
        <article-id pub-id-type="doi">10.1056/NEJMoa1301689</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS491910</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA491910</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <collab>The Cancer Genome Atlas Research Network</collab>
          </contrib>
        </contrib-group>
        <author-notes>
          <corresp id="FN1">Address reprint requests to Dr. Timothy J. Ley at Washington University School of Medicine, Division of Oncology, Stem Cell Biology Section, Campus Box 8007, 660 S. Euclid Ave., St. Louis, MO 63110, or at <email>timley@wustl.edu</email></corresp>
          <fn id="FN2" fn-type="other">
            <p>The members of the Cancer Genome Atlas Research Network are listed in the Appendix.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>01</day>
          <month>5</month>
          <year>2013</year>
        </pub-date>
        <pub-date pub-type="ppub">
          <day>30</day>
          <month>5</month>
          <year>2013</year>
        </pub-date>
        <volume>368</volume>
        <issue>22</issue>
        <issue-id pub-id-type="pmc-issue-id">227268</issue-id>
        <fpage>2059</fpage>
        <lpage>2074</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>25</day>
              <month>07</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>30</day>
              <month>11</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>30</day>
              <month>11</month>
              <year>2013</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2025-04-11 21:25:31.163">
              <day>11</day>
              <month>04</month>
              <year>2025</year>
            </date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement>Copyright © 2013 Massachusetts Medical Society.</copyright-statement>
          <copyright-year>2013</copyright-year>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms491910.pdf"/>
        <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="article-commentary" journal-id="N Engl J Med" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC4374653">
          <article-title>Genomic Landscapes and Clonality of De Novo AML</article-title>
          <volume>369</volume>
          <issue>15</issue>
          <date>
            <day>10</day>
            <month>10</month>
            <year>2013</year>
          </date>
          <fpage>1473</fpage>
          <lpage>1473</lpage>
          <source>The New England journal of medicine</source>
          <pub-id pub-id-type="pmcid">PMC4374653</pub-id>
          <pub-id pub-id-type="pmid">24106950</pub-id>
        </related-article>
        <related-article related-article-type="correction-forward" xml:lang="en" vol="369" page="98"/>
        <abstract>
          <sec id="S1">
            <title>BACKGROUND</title>
            <p id="P1">Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic phenotypes are not yet clear.</p>
          </sec>
          <sec id="S2">
            <title>METHODS</title>
            <p id="P2">We analyzed the genomes of 200 clinically annotated adult cases of de novo AML, using either whole-genome sequencing (50 cases) or whole-exome sequencing (150 cases), along with RNA and microRNA sequencing and DNA-methylation analysis.</p>
          </sec>
          <sec id="S3">
            <title>RESULTS</title>
            <p id="P3">AML genomes have fewer mutations than most other adult cancers, with an average of only 13 mutations found in genes. Of these, an average of 5 are in genes that are recurrently mutated in AML. A total of 23 genes were significantly mutated, and another 237 were mutated in two or more samples. Nearly all samples had at least 1 nonsynonymous mutation in one of nine categories of genes that are almost certainly relevant for pathogenesis, including transcription-factor fusions (18% of cases), the gene encoding nucleophosmin (<italic toggle="yes">NPM1</italic>) (27%), tumor-suppressor genes (16%), DNA-methylation–related genes (44%), signaling genes (59%), chromatin-modifying genes (30%), myeloid transcription-factor genes (22%), cohesin-complex genes (13%), and spliceosome-complex genes (14%). Patterns of cooperation and mutual exclusivity suggested strong biologic relationships among several of the genes and categories.</p>
          </sec>
          <sec id="S4">
            <title>CONCLUSIONS</title>
            <p id="P4">We identified at least one potential driver mutation in nearly all AML samples and found that a complex interplay of genetic events contributes to AML pathogenesis in individual patients. The databases from this study are widely available to serve as a foundation for further investigations of AML pathogenesis, classification, and risk stratification. (Funded by the National Institutes of Health.)</p>
          </sec>
        </abstract>
        <funding-group>
          <award-group>
            <funding-source country="United States">National Cancer Institute : NCI</funding-source>
            <award-id>P01 CA101937 || CA</award-id>
          </award-group>
        </funding-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
